VeriMom¿Debo evitar valproic acid durante el embarazo? | VeriMom
Valproic acid is a well‑documented human teratogen (increased risk of neural tube and other major malformations and adverse neurodevelopmental outcomes) and is reported with H360 (may damage fertility or the unborn child) in ECHA/registration/SDS sources, which per your calibration maps to h=3. Mechanistically VPA is a histone deacetylase (HDAC) inhibitor with well‑characterised effects on gene expression and placental/embryonic development; placental effects and placental transfer have been reported. Topical cosmetic use would likely give low but measurable systemic exposure compared with therapeutic dosing (so e=1 for pregnancy). (Sources: PubMed systematic reviews and clinical teratology literature; ECHA registration/SDS showing H360; mechanistic reviews on HDAC inhibition).
ECHA regulatory hazard statements
- •H360
- •H362
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ¿Es valproic acid seguro durante el embarazo?
- Valproic acid is a well‑documented human teratogen (increased risk of neural tube and other major malformations and adverse neurodevelopmental outcomes) and is reported with H360 (may damage fertility or the unborn child) in ECHA/registration/SDS sources, which per your calibration maps to h=3. Mechanistically VPA is a histone deacetylase (HDAC) inhibitor with well‑characterised effects on gene expression and placental/embryonic development; placental effects and placental transfer have been reported. Topical cosmetic use would likely give low but measurable systemic exposure compared with therapeutic dosing (so e=1 for pregnancy). (Sources: PubMed systematic reviews and clinical teratology literature; ECHA registration/SDS showing H360; mechanistic reviews on HDAC inhibition).
- ¿Es valproic acid seguro durante la lactancia?
- Valproic acid is listed with H362 (may cause harm to breast‑fed children) in ECHA/SDS documents and transfers into breast milk in clinical/toxicology literature; the mechanistic actions that produce developmental neurotoxicity are the same basis for concern. For a cosmetic topical route maternal systemic levels would usually be low, so exposure via breastmilk from cosmetic use is expected to be low but measurable (e=1).
- ¿Es valproic acid seguro para la piel del bebé?
- Hazard remains high because VPA is a confirmed human developmental/teratogenic agent and H360/H362 are reported; mechanism (HDAC inhibition, disruption of developmental signalling) is well characterised. If VPA were present on infant skin (0–3 yrs) dermal absorption is more significant than in adults; per your rules increase exposure by +1 when measurable — cosmetic topical adult e=1 becomes baby e=2. There are no infant‑topical specific safety data showing safe use on baby skin.
- ¿Cómo puntúa VeriMom a valproic acid?
- VeriMom puntúa valproic acid en 13/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a valproic acid en el embarazo?
- Consulta nuestra lista de alternativas seguras a valproic acid según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.